The Icahn School of Medicine at Mount Sinai in New York has opened the Centre for Ophthalmic Artificial Intelligence (AI) and Human Health, which aims to provide patient care with timely diagnosis.

The centre covers eye conditions and diseases such as glaucoma, hypertensive retinopathy, retinal tumours, macular degeneration, diabetic retinopathy and systemic conditions.

The centre will provide these services alongside the Windreich Department of Artificial Intelligence and Human Health at Icahn Mount Sinai.

Icahn Mount Sinai Artificial Intelligence and Human Health dean Thomas Fuchs said: “I am delighted to partner with Dr James Tsai and our colleagues at the distinguished New York Eye and Ear Infirmary of Mount Sinai in this groundbreaking initiative.

“At Mount Sinai, we can realise the vision of an AI-driven ophthalmology that will drastically improve care for nearly every patient visiting our hospitals.”

It will implement validated AI models across three initial areas, namely Mount Sinai’s eye stroke service, tele-retina programme and ophthalmology tele-consult programme.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The tele-retina programme captures retinal images during annual patient exams, while the teleophthalmology programme provides timely diagnosis and triage of patients with eye emergencies using telemedicine platforms.

Diagnosis and treatment of patients with an acute eye stroke (central retinal artery occlusion) will be conducted at Mount Sinai’s Eye Stroke Service.

Mount Sinai Health System Academic Affairs president Dennis Charney said: “Mount Sinai continues to be at the forefront of the artificial intelligence revolution, and taking an exciting new step into the field of ophthalmology to further collaborate across our health system to discover new approaches designed to solve complex health problems.

“This new centre further demonstrates our strong commitment to developing this field and train the next generation of leaders in eye care and ophthalmology research in novel areas involving technology and charting new areas of discovery that can quickly be implemented into everyday clinical practice.”